What Is HPLC Testing?

At a Glance

How HPLC Works

At its core, HPLC works by passing a liquid mobile phase—an aqueous or organic solvent mixture—through a tightly packed column of fine solid particles known as the stationary phase. When a sample is injected into this flowing stream, the compounds it contains interact with the stationary phase to different degrees. Compounds that interact more strongly with the stationary phase move through the column more slowly; compounds that interact more weakly elute faster. This differential retention is what separates the components.

The key elements of an HPLC system are:

• Pump — drives the mobile phase through the column at high pressure, typically several hundred to several thousand psi, which is what the “high-performance” designation refers to.
• Injector — introduces a precise volume of the dissolved sample into the pressurized mobile phase stream.
• Column — the stationary phase, where separation occurs. For peptide analysis this is most often a reverse-phase C18 column.
• Detector — measures a physical property of the eluting compounds, most commonly UV absorbance at a chosen wavelength, and converts it to an electrical signal.
• Data system — records detector response over time and renders it as a chromatogram.

Because each compound has a characteristic affinity for the stationary phase under a given set of conditions, it elutes at a reproducible retention time. By comparing the retention time and peak shape of a sample to those of a known reference standard, analysts can identify compounds and assess whether a sample contains only the intended research material or additional substances as well.

HPLC for Peptide Analysis

For peptide research reagents, the dominant HPLC mode is reverse-phase chromatography. In this configuration the stationary phase is hydrophobic—typically silica particles bonded with C18 (octadecyl) chains—while the mobile phase is a polar solvent such as water mixed with an organic modifier like acetonitrile. Peptides, which contain both polar and nonpolar regions, partition between the two phases according to their overall hydrophobicity, and this is what allows closely related sequences to be resolved from one another.

Several elements define a peptide HPLC method:

• C18 columns — the standard reverse-phase stationary phase for peptides and small proteins. C18 provides sufficient hydrophobic retention for sequences up to roughly 40–50 residues; longer or highly hydrophilic peptides may require C4 or C8 phases.
• Gradient elution — rather than running a single solvent composition, the mobile phase is changed continuously during a run, increasing the organic modifier percentage over time. This progressively elutes peptides of increasing hydrophobicity, compressing the run while resolving a wide range of components in a single chromatogram.
• Acidic modifiers — small amounts of trifluoroacetic acid (TFA) or formic acid are added to the mobile phase to protonate peptide termini and improve peak shape.
• UV detection — peptide bonds absorb strongly at 214 nm, making this the standard detection wavelength. Aromatic side chains allow detection at 280 nm as well. Diode-array detectors (DAD) record full UV spectra at each time point, aiding peak identification.

The result is a chromatogram in which the target peptide appears as a dominant peak at a characteristic retention time, while impurities—truncated sequences, deletion peptides, oxidized or deamidated variants, and residual synthesis reagents—appear as smaller, separate peaks at different retention times. The relative size of those peaks compared to the main peak is what the purity percentage expresses.

Reading an HPLC Chromatogram

A chromatogram is a plot of detector response (the y-axis) against time (the x-axis). Each compound that elutes from the column produces a peak. To evaluate peptide purity, researchers examine several features:

• Retention time — the time at which a peak maximum appears. The target peptide should elute at the same retention time as an authenticated reference standard under identical conditions.
• Peak area — the integrated area beneath a peak is proportional to the amount of that compound reaching the detector. Purity is calculated as the area of the principal peak divided by the sum of all integrated peak areas, expressed as a percentage.
• Peak shape — a symmetrical, narrow peak suggests a single well-resolved compound. Tailing, fronting, or shoulder peaks can indicate co-elution or column overload and may warrant re-analysis under adjusted conditions.
• Baseline — a clean, flat baseline between peaks indicates the detector is responding only to eluting compounds and not to noise or drifting mobile-phase composition.
• Minor peaks — small peaks at retention times distinct from the main peak represent impurities. Their number and combined area directly inform the purity value reported.

When a chromatogram shows a single dominant peak accounting for ≥99% of the total integrated area, with only trace-level minor peaks, the sample is reported as ≥99% pure. This value, along with the retention time and detection parameters, is recorded on the batch’s Certificate of Analysis. For an in-depth look at that document, see What Is a Certificate of Analysis (COA)?

What ≥99% Purity Means in Practice

When a research reagent is labeled ≥99% pure by HPLC, it means that under the analytical conditions specified on the COA, the integrated area of the peak corresponding to the target peptide accounts for at least 99% of the total integrated area of all detected peaks. In practical terms, the sample is overwhelmingly the intended compound; only trace levels of related substances are detectable.

It is important to understand what this figure does and does not convey:

This is why HPLC purity is reported alongside other data on a COA—mass spectrometry for identity, and sometimes Karl Fischer titration for residual moisture or elemental analysis for counter-ion content. Together these methods provide a fuller picture of reagent quality than any single value can. For researchers new to these concepts, What Are Peptides? offers foundational background on peptide structure and handling.

HPLC vs. Mass Spectrometry

HPLC and mass spectrometry (MS) answer different questions, and in peptide research they are most powerful when used together. Understanding the distinction is essential for interpreting a COA correctly.

HPLC separates the components of a mixture and quantifies their relative abundance, but it does not directly confirm what each component is at the molecular level. A peak at a given retention time is identified by comparison to a reference standard, not by direct measurement of molecular structure. HPLC therefore answers the question: how much of the sample is the target peptide, and how much is something else?

Mass spectrometry measures the mass-to-charge ratio (m/z) of ionized molecules. By comparing the observed mass of a peak to the calculated theoretical mass of the target peptide, MS confirms identity—whether the molecule present actually is the peptide claimed, rather than a near-relative or unrelated compound. MS answers the question: is the molecule the one it is reported to be?

The two methods are complementary, and many laboratories run them combined as LC-MS, where the HPLC separates the sample and the mass spectrometer analyzes each eluting peak in real time. The result is a chromatogram paired with mass data for every peak, giving both purity quantification and identity confirmation in a single run. A thorough COA will report both an HPLC purity percentage and a mass-spectrometric identity result.

For related methodology, see What Is Lyophilization? to understand how freeze-drying preserves the peptide stability that HPLC verifies.